INS and Hypoglycemia: All three major U.S. diabetes professional societies have provided evidence-based guidance on the use of CGM for patients with T2D.58–61 All professional organizations have recommended CGM use in selected patients with T2D to improve glycemic control or reduce hypoglycemia, while acknowledging limited and low-quality evidence, especially non-insulin-treated T2D.